Splicing of distant peptide fragments occurs in the proteasome by transpeptidation and produces the spliced antigenic peptide derived from fibroblast growth factor-5

Journal of Immunology

Volumn 184, Issue 6, 2010, Pages 3016-3024

  Dalet, Alexandre ^a   Vigneron, Nathalie ^a   Stroobant, Vincent ^a   Hanada, Ken Ichi ^b   Van Den Eynde, Benoît J ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 5; PEPTIDE FRAGMENT; PROTEASOME; PROTEIN PRECURSOR; ANTIGEN; FGF5 PROTEIN, HUMAN;

ANTIGENIC MODULATION; ARTICLE; CATALYSIS; CONTROLLED STUDY; DNA SPLICING; HUMAN; HUMAN CELL; IN VITRO STUDY; PLASMID; PRECURSOR; PRIORITY JOURNAL; PROTEIN PROCESSING; TRANS SPLICING; AMINO ACID SEQUENCE; ANIMAL; ANTIGEN PRESENTATION; BIOSYNTHESIS; CELL LINE; CELL STRAIN COS1; CERCOPITHECUS; CHEMISTRY; CYTOTOXICITY TEST; DRUG ANTAGONISM; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; CELL LINE; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOTOXICITY TESTS, IMMUNOLOGIC; FIBROBLAST GROWTH FACTOR 5; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PRECURSORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN SPLICING; TRANSFECTION;

EID: 77951926376     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901277     Document Type: Article

References (24)

1. Rock, K. L., and A. L. Goldberg. 1999. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 17: 739-779.
2. Peters, J. M., Z. Cejka, J. R. Harris, J. A. Kleinschmidt, and W. Baumeister. 1993. Structural features of the 26 S proteasome complex. J. Mol. Biol. 234: 932-937.
3. Löwe, J., D. Stock, B. Jap, P. Zwickl, W. Baumeister, and R. Huber. 1995. Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution. Science 268: 533-539.
4. Groll, M., L. Ditzel, J. Löwe, D. Stock, M. Bochtler, H. D. Bartunik, and R. Huber. 1997. Structure of 20S proteasome from yeast at 2.4 A resolution. Nature 386: 463-471. (Pubitemid 27164066)
5. Heinemeyer, W., M. Fischer, T. Krimmer, U. Stachon, and D. H. Wolf. 1997. The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing. J. Biol. Chem. 272: 25200-25209.
6. Seemüller, E., A. Lupas, D. Stock, J. Löwe, R. Huber, and W. Baumeister. 1995. Proteasome from Thermoplasma acidophilum: a threonine protease. Science 268: 579-582.
7. Brannigan, J. A., G. Dodson, H. J. Duggleby, P. C. Moody, J. L. Smith, D. R. Tomchick, and A. G. Murzin. 1995. A protein catalytic framework with an N-terminal nucleophile is capable of self-activation. Nature 378: 416-419.
8. Hanada, K., J. W. Yewdell, and J. C. Yang. 2004. Immune recognition of a human renal cancer antigen through post-translational protein splicing. Nature 427: 252-256. (Pubitemid 38112041)
9. Vigneron, N., V. Stroobant, J. Chapiro, A. Ooms, G. Degiovanni, S. Morel, P. van der Bruggen, T. Boon, and B. J. Van den Eynde. 2004. An antigenic peptide produced by peptide splicing in the proteasome. Science 304: 587-590.
10. Warren, E. H., N. J. Vigneron, M. A. Gavin, P. G. Coulie, V. Stroobant, A. Dalet, S. S. Tykodi, S. M. Xuereb, J. K. Mito, S. R. Riddell, and B. J. Van den Eynde. 2006. An antigen produced by splicing of noncontiguous peptides in the reverse order. Science 313: 1444-1447.
11. Berkers, C. R., A. de Jong, H. Ovaa, and B. Rodenko. 2009. Transpeptidation and reverse proteolysis and their consequences for immunity. Int. J. Biochem. Cell Biol. 41: 66-71.
12. Germeau, C., W. Ma, F. Schiavetti, C. Lurquin, E. Henry, N. Vigneron, F. Brasseur, B. Lethé, E. De Plaen, T. Velu, et al. 2005. High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens. J. Exp. Med. 201: 241-248.
13. Murata, M., E. H. Warren, and S. R. Riddell. 2003. A human minor histocompatibility antigen resulting from differential expression due to a gene deletion. J. Exp. Med. 197: 1279-1289.
14. Uyttenhove, C., L. Pilotte, I. Théate, V. Stroobant, D. Colau, N. Parmentier, T. Boon, and B. J. Van den Eynde. 2003. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat. Med. 9: 1269-1274.
15. Chapiro, J., S. Claverol, F. Piette, W. Ma, V. Stroobant, B. Guillaume, J.- E. Gairin, S. Morel, O. Burlet-Schiltz, B. Monsarrat, et al. 2006. Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentation. J. Immunol. 176: 1053-1061.
16. Bates, B., J. Hardin, X. Zhan, K. Drickamer, and M. Goldfarb. 1991. Biosynthesis of human fibroblast growth factor-5. Mol. Cell. Biol. 11: 1840-1845.
17. Whitby, F. G., E. I. Masters, L. Kramer, J. R. Knowlton, Y. Yao, C. C. Wang, and C. P. Hill. 2000. Structural basis for the activation of 20S proteasomes by 11S regulators. Nature 408: 115-120.
18. Lee, C., S. Prakash, and A. Matouschek. 2002. Concurrent translocation of multiple polypeptide chains through the proteasomal degradation channel. J. Biol. Chem. 277: 34760-34765.
19. Sharon, M., S. Witt, K. Felderer, B. Rockel, W. Baumeister, and C. V. Robinson. 2006. 20S proteasomes have the potential to keep substrates in store for continual degradation. J. Biol. Chem. 281: 9569-9575.
20. Hutschenreiter, S., A. Tinazli, K. Model, and R. Tampé. 2004. Two-substrate association with the 20S proteasome at single-molecule level. EMBO J. 23: 2488-2497.
21. Borissenko, L., and M. Groll. 2007. Diversity of proteasomal missions: fine tuning of the immune response. Biol. Chem. 388: 947-955.
22. Akopian, T. N., A. F. Kisselev, and A. L. Goldberg. 1997. Processive degradation of proteins and other catalytic properties of the proteasome from Thermoplasma acidophilum. J. Biol. Chem. 272: 1791-1798.
23. Groll, M., M. Götz, M. Kaiser, E. Weyher, and L. Moroder. 2006. TMC-95-based inhibitor design provides evidence for the catalytic versatility of the proteasome. Chem. Biol. 13: 607-614.
24. Pavlov, M. Y., R. E. Watts, Z. Tan, V. W. Cornish, M. Ehrenberg, and A. C. Forster. 2009. Slow peptide bond formation by proline and other N-alkylamino acids in translation. Proc. Natl. Acad. Sci. USA 106: 50-54.